Warning: session_start() [function.session-start]: open(/var/lib/php/session/sess_869gh2uh3l90c038qcjvit6455, O_RDWR) failed: Permission denied (13) in /var/www/html/realclearpolitics.com/httpdocs/congressional_bill_tracker/app/application/mvc.php on line 3

Warning: file_get_contents(http://congress.api.sunlightfoundation.com/bills?apikey=f323a285321542e3925601990ef5c589&congress=114&bill_type=hr&number=2480&fields=versions,latest_version) [function.file-get-contents]: failed to open stream: HTTP request failed! HTTP/1.1 504 Gateway Time-out in /var/www/html/realclearpolitics.com/httpdocs/congressional_bill_tracker/app/application/model.php on line 738
RCP Congressional Bill Tracker - H.R. 2480

CONGRESSIONAL BILL TRACKER

Track Members of Congress & Get Email Updates on Their Activity

H.R. 2480: CCM-CARE Act

Title: CCM-CARE Act

Introduced: May 20, 2015 (114th Congress)

Sponsor: (No First Name Found) (No Last Name Found) [-]

Status: Referred to Committee - Referred to the Subcommittee on Health.

Summary: Cerebral Cavernous Malformations Clinical Awareness, Research, and Education Act of 2015 or the CCM-CARE Act This bill amends the Public Health Service Act to require the National Institutes of Health (NIH) to strengthen and coordinate its efforts concerning cerebral cavernous malformation (CCM). (CCM is a condition in which blood vessels in the brain and spinal cord become enlarged, which can lead to seizures, paralysis, hearing or vision loss, or bleeding in the brain.) The NIH may award grants and enter into cooperative agreements for CCM research. The NIH must: (1) award grants and contracts to plan and provide support for a network of CCM Clinical Research Centers; (2) identify and support additional centers to facilitate medical research to develop a cure for CCM and enhance medical care for CCM; and (3) convene a Cerebral Cavernous Malformations Research Consortium to develop programs for clinicians, scientists, and patients. The Centers for Disease Control and Prevention may award grants and enter into cooperative agreements for the collection, analysis, and reporting of data on CCM. The Department of Health and Human Services must award grants and enter into cooperative agreements for epidemiological activities related to CCM and must provide for a national CCM surveillance program. The Food and Drug Administration must: (1) coordinate with clinical centers, investigators, and advocates to support investigational new drug applications in order to hasten clinical trials for CCM, and (2) support appropriate requests for designation of drugs for use in rare subpopulations of CCM patients as orphan drugs. (Orphan drugs are drugs developed to treat rare medical conditions and are eligible for certain incentives.)

Votes


Warning: Unknown: open(/var/lib/php/session/sess_869gh2uh3l90c038qcjvit6455, O_RDWR) failed: Permission denied (13) in Unknown on line 0

Warning: Unknown: Failed to write session data (files). Please verify that the current setting of session.save_path is correct (/var/lib/php/session) in Unknown on line 0